Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Cash Flows

v3.3.0.814
Condensed Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Operating activities:    
Net loss $ (14,945) $ (13,614)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization $ 653 535
Inventory allowance expense 21
Amortization of deferred rent $ (28) (27)
Amortization of debt discounts 191
Stock-based compensation expense $ 1,259 810
Loss on increase in fair value of warrant liability 1,206
Changes in operating assets and liabilities:    
Accounts receivable $ (636) (1,372)
Inventories (379) (161)
Prepaid expense and other assets (338) (80)
Deferred cost of revenue (776) (1,541)
Accounts payable 1,365 (422)
Accrued liabilities (188) (108)
Deferred revenues 931 2,266
Net cash used in operating activities (13,082) (12,296)
Investing activities:    
Acquisition of property and equipment, net $ (962) (917)
Note receivable from stockholder 104
Net cash used in investing activities $ (962) (813)
Financing activities:    
Principal payments on notes payable (40) $ (2,547)
Proceeds from exercise of stock options 80
Proceeds from exercise of common stock warrants $ 52
Proceeds from issuance of common stock, net of issuance costs $ 22,027
Net cash provided by financing activities $ 92 19,480
Net increase (decrease) in cash (13,952) 6,371
Cash at beginning of the period 25,190 805
Cash at end of the period $ 11,238 $ 7,176